Abstract
Infliximab is a TNF-alpha inhibitor in the form of a chimeric monoclonal antibody. It received FDA approval in 2006 for the treatment of adult patient......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
